Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment: (questionable) classification of diabetic patients based on combination of specific glucose-lowering drugs

被引:2
|
作者
Holden, Sarah E. [1 ]
Bannister, Christian A. [1 ]
Currie, Craig J. [1 ]
机构
[1] Cardiff Univ, Cardiff Medictr, Pharma Res Ctr, Sch Med, Cardiff CF14 4UJ, S Glam, Wales
基金
英国医学研究理事会;
关键词
Cancer; Diabetes; Diabetes duration; Insulin; Mortality; Treatment;
D O I
10.1007/s00125-014-3281-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2001 / 2002
页数:2
相关论文
共 50 条
  • [1] Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment: (questionable) classification of diabetic patients based on combination of specific glucose-lowering drugs
    Sarah E. Holden
    Christian A. Bannister
    Craig J. Currie
    Diabetologia, 2014, 57 : 2001 - 2002
  • [2] Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment: (questionable) classification of diabetic patients based on combination of specific glucose-lowering drugs. Reply to Holden SE, Bannister CA, Currie CJ [letter]
    Ranc, Kristina
    Jorgensen, Marit E.
    Friis, Soren
    Carstensen, Bendix
    DIABETOLOGIA, 2014, 57 (09) : 2003 - 2004
  • [3] Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment: (questionable) classification of diabetic patients based on combination of specific glucose-lowering drugs. Reply to Holden SE, Bannister CA, Currie CJ [letter]
    Kristina Ranc
    Marit E. Jørgensen
    Søren Friis
    Bendix Carstensen
    Diabetologia, 2014, 57 : 2003 - 2004
  • [4] Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment
    Ranc, Kristina
    Jorgensen, Marit E.
    Friis, Soren
    Carstensen, Bendix
    DIABETOLOGIA, 2014, 57 (05) : 927 - 934
  • [5] Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment
    Kristina Ranc
    Marit E. Jørgensen
    Søren Friis
    Bendix Carstensen
    Diabetologia, 2014, 57 : 927 - 934
  • [6] Association between glucose-lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancy
    Noh, Yoojin
    Jeon, Sang-Min
    Shin, Sooyoung
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (07) : 1530 - 1539
  • [7] The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes
    Khalangot, Mykola
    Tronko, Mykola
    Kravchenko, Victor
    Kulchinska, Jaroslava
    Hu, Gang
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 82 (01) : 139 - 147
  • [8] The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes
    Pauline A. J. Vissers
    Chris R. Cardwell
    Lonneke V. van de Poll-Franse
    Ian S. Young
    Frans Pouwer
    Liam J. Murray
    Breast Cancer Research and Treatment, 2015, 150 : 427 - 437
  • [9] The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes
    Vissers, Pauline A. J.
    Cardwell, Chris R.
    van de Poll-Franse, Lonneke V.
    Young, Ian S.
    Pouwer, Frans
    Murray, Liam J.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (02) : 427 - 437
  • [10] Long-term mortality in patients with type 2 diabetes undergoing coronary angiography: the impact of glucose-lowering treatment
    Saleh, N.
    Petursson, P.
    Lagerqvist, B.
    Skuladottir, H.
    Svensson, A.
    Eliasson, B.
    Gudbjornsdottir, S.
    Eeg-Olofsson, K.
    Norhammar, A.
    DIABETOLOGIA, 2012, 55 (08) : 2109 - 2117